Image: Malin Grönborg
Cancer is a malignant disease and one of the most common causes of death in our time. The aim of studying cancer is to develop safe and effective methods to prevent, detect, diagnose, treat and ultimately cure the various diseases known as cancer. The better we understand these diseases, the more progress we will make towards reducing the human suffering and economic costs of cancer.
Clinical cancer research is patient-oriented research in close collaboration with the health care system.
We need a greater understanding of the molecular mechanisms behind the spread of cancer.
Translational research bridges the gap between laboratory-based science and cancer treatment in clinic.
By disrupting the genetic instructions that produce c-Myc, researchers can slow the growth of cancer cells.
The Organisation of European Cancer Institutes gives green light for the next phase: an on-site review visit.
Most cancer drugs target proteins. This strategy instead targets the virus's DNA.
The researchers, led by Maréne Landström, have developed a so-called fully human antibody.
The new study shows that the protein METTL3 helps breast cancer cells spread.
The study shows that palliative patients neither live longer nor experience improved quality of life.